Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Oncology/Hematology Market Research

Global Stomach Cancer Treatment Databank Market Report

Best Price Guarantee Length Publisher Published Date SKU
from $2,000 100 Pages Magna Intelligence April, 2024 MAIN18750476
Best Price Guarantee
Price from $2,000
Length 100 Pages
Publisher Magna Intelligence
Published Date April, 2024
SKU MAIN18750476

Global Stomach Cancer Treatment Databank Market Report


The Stomach Cancer Treatment market was valued at $4,211.5 Million in 2022, and is projected to reach $10,511.7 Million by 2031 growing at a CAGR of 10.76% from 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $2,319.0 Million in 2022, and is anticipated to reach $5,613.5 Million by 2031, registering a CAGR of 10.38%. Chemotherapy segment is anticipated to reach $777.5 Million by 2031 with the highest CAGR of 12.69%. Targeted Therapy and Immunotherapy segments collectively expected to account for about 93.7% share of the Stomach Cancer Treatment market in 2022, with the former constituting around 55.1% share. Chemotherapy and Immunotherapy segments are expected to witness significant growth rates at a CAGR of 12.69% and 10.94% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 44.9% in the overall Stomach Cancer Treatment market in 2022, and is anticipated to reach 46.6% by 2031.


1. Global Stomach Cancer Treatment Market, By Treatment Type
1.1. Overview
1.2. Immunotherapy
1.2.1 Immunotherapy Market, By Region
1.2.1.1 North America Immunotherapy Market, By Country
1.2.1.2 Europe Immunotherapy Market, By Country
1.2.1.3 Asia-Pacific Immunotherapy Market, By Country
1.2.1.4 Rest of World Immunotherapy Market, By Country
1.3. Targeted Therapy
1.3.1 Targeted Therapy Market, By Region
1.3.1.1 North America Targeted Therapy Market, By Country
1.3.1.2 Europe Targeted Therapy Market, By Country
1.3.1.3 Asia-Pacific Targeted Therapy Market, By Country
1.3.1.4 Rest of World Targeted Therapy Market, By Country
1.4. Chemotherapy
1.4.1 Chemotherapy Market, By Region
1.4.1.1 North America Chemotherapy Market, By Country
1.4.1.2 Europe Chemotherapy Market, By Country
1.4.1.3 Asia-Pacific Chemotherapy Market, By Country
1.4.1.4 Rest of World Chemotherapy Market, By Country
2. Global Stomach Cancer Treatment Market, By Disease Indication
2.1. Overview
2.2. Gastric Cancer/Gastroesophageal Junction Cancer
2.2.1 Gastric Cancer/Gastroesophageal Junction Cancer Market, By Region
2.2.1.1 North America Gastric Cancer/Gastroesophageal Junction Cancer Market, By Country
2.2.1.2 Europe Gastric Cancer/Gastroesophageal Junction Cancer Market, By Country
2.2.1.3 Asia-Pacific Gastric Cancer/Gastroesophageal Junction Cancer Market, By Country
2.2.1.4 Rest of World Gastric Cancer/Gastroesophageal Junction Cancer Market, By Country
2.3. Gastrointestinal Stromal Tumors
2.3.1 Gastrointestinal Stromal Tumors Market, By Region
2.3.1.1 North America Gastrointestinal Stromal Tumors Market, By Country
2.3.1.2 Europe Gastrointestinal Stromal Tumors Market, By Country
2.3.1.3 Asia-Pacific Gastrointestinal Stromal Tumors Market, By Country
2.3.1.4 Rest of World Gastrointestinal Stromal Tumors Market, By Country
3. Global Stomach Cancer Treatment Market, By Route of Administration
3.1. Overview
3.2. Oral
3.2.1 Oral Market, By Region
3.2.1.1 North America Oral Market, By Country
3.2.1.2 Europe Oral Market, By Country
3.2.1.3 Asia-Pacific Oral Market, By Country
3.2.1.4 Rest of World Oral Market, By Country
3.3. Injectable
3.3.1 Injectable Market, By Region
3.3.1.1 North America Injectable Market, By Country
3.3.1.2 Europe Injectable Market, By Country
3.3.1.3 Asia-Pacific Injectable Market, By Country
3.3.1.4 Rest of World Injectable Market, By Country
4. Global Stomach Cancer Treatment Market, By Drug Class
4.1. Overview
4.2. PD-1/PD-L1 Inhibitors
4.2.1 PD-1/PD-L1 Inhibitors Market, By Region
4.2.1.1 North America PD-1/PD-L1 Inhibitors Market, By Country
4.2.1.2 Europe PD-1/PD-L1 Inhibitors Market, By Country
4.2.1.3 Asia-Pacific PD-1/PD-L1 Inhibitors Market, By Country
4.2.1.4 Rest of World PD-1/PD-L1 Inhibitors Market, By Country
4.3. HER2 Antagonists
4.3.1 HER2 Antagonists Market, By Region
4.3.1.1 North America HER2 Antagonists Market, By Country
4.3.1.2 Europe HER2 Antagonists Market, By Country
4.3.1.3 Asia-Pacific HER2 Antagonists Market, By Country
4.3.1.4 Rest of World HER2 Antagonists Market, By Country
4.4. VEGFR2 Antagonists
4.4.1 VEGFR2 Antagonists Market, By Region
4.4.1.1 North America VEGFR2 Antagonists Market, By Country
4.4.1.2 Europe VEGFR2 Antagonists Market, By Country
4.4.1.3 Asia-Pacific VEGFR2 Antagonists Market, By Country
4.4.1.4 Rest of World VEGFR2 Antagonists Market, By Country
4.5. Other Drug Classes
4.5.1 Other Drug Classes Market, By Region
4.5.1.1 North America Other Drug Classes Market, By Country
4.5.1.2 Europe Other Drug Classes Market, By Country
4.5.1.3 Asia-Pacific Other Drug Classes Market, By Country
4.5.1.4 Rest of World Other Drug Classes Market, By Country
5. Global Stomach Cancer Treatment Market, By Region
5.1. Overview
5.2. North America
5.2.1 North America Stomach Cancer Treatment Market, By Treatment Type
5.2.2 North America Stomach Cancer Treatment Market, By Disease Indication
5.2.3 North America Stomach Cancer Treatment Market, By Route of Administration
5.2.4 North America Stomach Cancer Treatment Market, By Drug Class
5.2.5 North America Stomach Cancer Treatment Market, By Country
5.2.5.1 U.S.
5.2.5.1.1 U.S. Stomach Cancer Treatment Market, By Treatment Type
5.2.5.1.2 U.S. Stomach Cancer Treatment Market, By Disease Indication
5.2.5.1.3 U.S. Stomach Cancer Treatment Market, By Route of Administration
5.2.5.1.4 U.S. Stomach Cancer Treatment Market, By Drug Class
5.2.5.2 Canada
5.2.5.2.1 Canada Stomach Cancer Treatment Market, By Treatment Type
5.2.5.2.2 Canada Stomach Cancer Treatment Market, By Disease Indication
5.2.5.2.3 Canada Stomach Cancer Treatment Market, By Route of Administration
5.2.5.2.4 Canada Stomach Cancer Treatment Market, By Drug Class
5.3. Europe
5.3.1 Europe Stomach Cancer Treatment Market, By Treatment Type
5.3.2 Europe Stomach Cancer Treatment Market, By Disease Indication
5.3.3 Europe Stomach Cancer Treatment Market, By Route of Administration
5.3.4 Europe Stomach Cancer Treatment Market, By Drug Class
5.3.5 Europe Stomach Cancer Treatment Market, By Country
5.3.5.1 Germany
5.3.5.1.1 Germany Stomach Cancer Treatment Market, By Treatment Type
5.3.5.1.2 Germany Stomach Cancer Treatment Market, By Disease Indication
5.3.5.1.3 Germany Stomach Cancer Treatment Market, By Route of Administration
5.3.5.1.4 Germany Stomach Cancer Treatment Market, By Drug Class
5.3.5.2 U.K.
5.3.5.2.1 U.K. Stomach Cancer Treatment Market, By Treatment Type
5.3.5.2.2 U.K. Stomach Cancer Treatment Market, By Disease Indication
5.3.5.2.3 U.K. Stomach Cancer Treatment Market, By Route of Administration
5.3.5.2.4 U.K. Stomach Cancer Treatment Market, By Drug Class
5.3.5.3 France
5.3.5.3.1 France Stomach Cancer Treatment Market, By Treatment Type
5.3.5.3.2 France Stomach Cancer Treatment Market, By Disease Indication
5.3.5.3.3 France Stomach Cancer Treatment Market, By Route of Administration
5.3.5.3.4 France Stomach Cancer Treatment Market, By Drug Class
5.3.5.4 Italy
5.3.5.4.1 Italy Stomach Cancer Treatment Market, By Treatment Type
5.3.5.4.2 Italy Stomach Cancer Treatment Market, By Disease Indication
5.3.5.4.3 Italy Stomach Cancer Treatment Market, By Route of Administration
5.3.5.4.4 Italy Stomach Cancer Treatment Market, By Drug Class
5.3.5.5 Spain
5.3.5.5.1 Spain Stomach Cancer Treatment Market, By Treatment Type
5.3.5.5.2 Spain Stomach Cancer Treatment Market, By Disease Indication
5.3.5.5.3 Spain Stomach Cancer Treatment Market, By Route of Administration
5.3.5.5.4 Spain Stomach Cancer Treatment Market, By Drug Class
5.3.5.6 Rest of Europe
5.3.5.6.1 Rest of Europe Stomach Cancer Treatment Market, By Treatment Type
5.3.5.6.2 Rest of Europe Stomach Cancer Treatment Market, By Disease Indication
5.3.5.6.3 Rest of Europe Stomach Cancer Treatment Market, By Route of Administration
5.3.5.6.4 Rest of Europe Stomach Cancer Treatment Market, By Drug Class
5.4. Asia-Pacific
5.4.1 Asia-Pacific Stomach Cancer Treatment Market, By Treatment Type
5.4.2 Asia-Pacific Stomach Cancer Treatment Market, By Disease Indication
5.4.3 Asia-Pacific Stomach Cancer Treatment Market, By Route of Administration
5.4.4 Asia-Pacific Stomach Cancer Treatment Market, By Drug Class
5.4.5 Asia-Pacific Stomach Cancer Treatment Market, By Country
5.4.5.1 China
5.4.5.1.1 China Stomach Cancer Treatment Market, By Treatment Type
5.4.5.1.2 China Stomach Cancer Treatment Market, By Disease Indication
5.4.5.1.3 China Stomach Cancer Treatment Market, By Route of Administration
5.4.5.1.4 China Stomach Cancer Treatment Market, By Drug Class
5.4.5.2 Japan
5.4.5.2.1 Japan Stomach Cancer Treatment Market, By Treatment Type
5.4.5.2.2 Japan Stomach Cancer Treatment Market, By Disease Indication
5.4.5.2.3 Japan Stomach Cancer Treatment Market, By Route of Administration
5.4.5.2.4 Japan Stomach Cancer Treatment Market, By Drug Class
5.4.5.3 South Korea
5.4.5.3.1 5.4.5.3.2
South Korea Stomach Cancer Treatment Market, By Disease Indication 5.4.5.3.3
South Korea Stomach Cancer Treatment Market, By Route of Administration 5.4.5.3.4
South Korea Stomach Cancer Treatment Market, By Drug Class 5.4.5.4
India 5.4.5.4.1
India Stomach Cancer Treatment Market, By Treatment Type 5.4.5.4.2
India Stomach Cancer Treatment Market, By Disease Indication 5.4.5.4.3
India Stomach Cancer Treatment Market, By Route of Administration 5.4.5.4.4
India Stomach Cancer Treatment Market, By Drug Class 5.4.5.5
Singapore 5.4.5.5.1
Singapore Stomach Cancer Treatment Market, By Treatment Type 5.4.5.5.2
Singapore Stomach Cancer Treatment Market, By Disease Indication 5.4.5.5.3
Singapore Stomach Cancer Treatment Market, By Route of Administration 5.4.5.5.4
Singapore Stomach Cancer Treatment Market, By Drug Class 5.4.5.6
Rest of Asia 5.4.5.6.1
Rest of Asia Stomach Cancer Treatment Market, By Treatment Type 5.4.5.6.2
Rest of Asia Stomach Cancer Treatment Market, By Disease Indication 5.4.5.6.3
Rest of Asia Stomach Cancer Treatment Market, By Route of Administration 5.4.5.6.4
Rest of Asia Stomach Cancer Treatment Market, By Drug Class 5.5.
Rest of World 5.5.1
Rest of World Stomach Cancer Treatment Market, By Treatment Type 5.5.2
Rest of World Stomach Cancer Treatment Market, By Disease Indication 5.5.3
Rest of World Stomach Cancer Treatment Market, By Route of Administration 5.5.4
Rest of World Stomach Cancer Treatment Market, By Drug Class 5.5.5
Rest of World Stomach Cancer Treatment Market, By Country 5.5.5.1
Brazil 5.5.5.1.1
Brazil Stomach Cancer Treatment Market, By Treatment Type 5.5.5.1.2
Brazil Stomach Cancer Treatment Market, By Disease Indication 5.5.5.1.3
Brazil Stomach Cancer Treatment Market, By Route of Administration 5.5.5.1.4
Brazil Stomach Cancer Treatment Market, By Drug Class 5.5.5.2
Mexico 5.5.5.2.1
Mexico Stomach Cancer Treatment Market, By Treatment Type 5.5.5.2.2
Mexico Stomach Cancer Treatment Market, By Disease Indication 5.5.5.2.3
Mexico Stomach Cancer Treatment Market, By Route of Administration 5.5.5.2.4
Mexico Stomach Cancer Treatment Market, By Drug Class 5.5.5.3
South Africa 5.5.5.3.1
South Africa Stomach Cancer Treatment Market, By Treatment Type 5.5.5.3.2
South Africa Stomach Cancer Treatment Market, By Disease Indication 5.5.5.3.3
South Africa Stomach Cancer Treatment Market, By Route of Administration 5.5.5.3.4
South Africa Stomach Cancer Treatment Market, By Drug Class 5.5.5.4
Australia 5.5.5.4.1
Australia Stomach Cancer Treatment Market, By Treatment Type 5.5.5.4.2
Australia Stomach Cancer Treatment Market, By Disease Indication 5.5.5.4.3
Australia Stomach Cancer Treatment Market, By Route of Administration 5.5.5.4.4
Australia Stomach Cancer Treatment Market, By Drug Class 5.5.5.5
ROW Countries 5.5.5.5.1
ROW Countries Stomach Cancer Treatment Market, By Treatment Type 5.5.5.5.2
ROW Countries Stomach Cancer Treatment Market, By Disease Indication 5.5.5.5.3
ROW Countries Stomach Cancer Treatment Market, By Route of Administration 5.5.5.5.4
ROW Countries Stomach Cancer Treatment Market, By Drug Class ROW Countries Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USDLIST OF TABLES
TABLE 1. Global Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 2. Immunotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 7. Targeted Therapy Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 12. Chemotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 17. Global Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 18. Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 19. North America Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 20. Europe Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 21. Asia-Pacific Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 22. Rest of World Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 23. Gastrointestinal Stromal Tumors Market Value, By Region, 2022-2031, Million USD
TABLE 24. North America Gastrointestinal Stromal Tumors Market Value, By Country, 2022-2031, Million USD
TABLE 25. Europe Gastrointestinal Stromal Tumors Market Value, By Country, 2022-2031, Million USD
TABLE 26. Asia-Pacific Gastrointestinal Stromal Tumors Market Value, By Country, 2022-2031, Million USD
TABLE 27. Rest of World Gastrointestinal Stromal Tumors Market Value, By Country, 2022-2031, Million USD
TABLE 28. Global Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 29. Oral Market Value, By Region, 2022-2031, Million USD
TABLE 30. North America Oral Market Value, By Country, 2022-2031, Million USD
TABLE 31. Europe Oral Market Value, By Country, 2022-2031, Million USD
TABLE 32. Asia-Pacific Oral Market Value, By Country, 2022-2031, Million USD
TABLE 33. Rest of World Oral Market Value, By Country, 2022-2031, Million USD
TABLE 34. Injectable Market Value, By Region, 2022-2031, Million USD
TABLE 35. North America Injectable Market Value, By Country, 2022-2031, Million USD
TABLE 36. Europe Injectable Market Value, By Country, 2022-2031, Million USD
TABLE 37. Asia-Pacific Injectable Market Value, By Country, 2022-2031, Million USD
TABLE 38. Rest of World Injectable Market Value, By Country, 2022-2031, Million USD
TABLE 39. Global Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 40. PD-1/PD-L1 Inhibitors Market Value, By Region, 2022-2031, Million USD
TABLE 41. North America PD-1/PD-L1 Inhibitors Market Value, By Country, 2022-2031, Million USD
TABLE 42. Europe PD-1/PD-L1 Inhibitors Market Value, By Country, 2022-2031, Million USD
TABLE 43. Asia-Pacific PD-1/PD-L1 Inhibitors Market Value, By Country, 2022-2031, Million USD
TABLE 44. Rest of World PD-1/PD-L1 Inhibitors Market Value, By Country, 2022-2031, Million USD
TABLE 45. HER2 Antagonists Market Value, By Region, 2022-2031, Million USD
TABLE 46. North America HER2 Antagonists Market Value, By Country, 2022-2031, Million USD
TABLE 47. Europe HER2 Antagonists Market Value, By Country, 2022-2031, Million USD
TABLE 48. Asia-Pacific HER2 Antagonists Market Value, By Country, 2022-2031, Million USD
TABLE 49. Rest of World HER2 Antagonists Market Value, By Country, 2022-2031, Million USD
TABLE 50. VEGFR2 Antagonists Market Value, By Region, 2022-2031, Million USD
TABLE 51. North America VEGFR2 Antagonists Market Value, By Country, 2022-2031, Million USD
TABLE 52. Europe VEGFR2 Antagonists Market Value, By Country, 2022-2031, Million USD
TABLE 53. Asia-Pacific VEGFR2 Antagonists Market Value, By Country, 2022-2031, Million USD
TABLE 54. Rest of World VEGFR2 Antagonists Market Value, By Country, 2022-2031, Million USD
TABLE 55. Other Drug Classes Market Value, By Region, 2022-2031, Million USD
TABLE 56. North America Other Drug Classes Market Value, By Country, 2022-2031, Million USD
TABLE 57. Europe Other Drug Classes Market Value, By Country, 2022-2031, Million USD
TABLE 58. Asia-Pacific Other Drug Classes Market Value, By Country, 2022-2031, Million USD
TABLE 59. Rest of World Other Drug Classes Market Value, By Country, 2022-2031, Million USD
TABLE 60. Global Stomach Cancer Treatment Market Value, By Region, 2022-2031, Million USD
TABLE 61. North America Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 62. North America Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 63. North America Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 64. North America Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 65. North America Stomach Cancer Treatment Market Value, By Country, 2022-2031, Million USD
TABLE 66. U.S. Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 67. U.S. Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 68. U.S. Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 69. U.S. Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 70. Canada Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 71. Canada Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 72. Canada Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 73. Canada Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 74. Europe Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 75. Europe Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 76. Europe Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 77. Europe Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 78. Europe Stomach Cancer Treatment Market Value, By Country, 2022-2031, Million USD
TABLE 79. Germany Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 80. Germany Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 81. Germany Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 82. Germany Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 83. U.K. Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 84. U.K. Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 85. U.K. Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 86. U.K. Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 87. France Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 88. France Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 89. France Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 90. France Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 91. Italy Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 92. Italy Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 93. Italy Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 94. Italy Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 95. Spain Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 96. Spain Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 97. Spain Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 98. Spain Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 99. Rest of Europe Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 100. Rest of Europe Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 101. Rest of Europe Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 102. Rest of Europe Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 103. Asia-Pacific Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 104. Asia-Pacific Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 105. Asia-Pacific Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 106. Asia-Pacific Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 107. Asia-Pacific Stomach Cancer Treatment Market Value, By Country, 2022-2031, Million USD
TABLE 108. China Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 109. China Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 110. China Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 111. China Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 112. Japan Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 113. Japan Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 114. Japan Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 115. Japan Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 116. South Korea Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 117. South Korea Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 118. South Korea Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 119. India Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 120. India Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 121. India Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 122. India Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 123. Singapore Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 124. Singapore Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 125. Singapore Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 126. Singapore Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 127. Rest of Asia Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 128. Rest of Asia Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 129. Rest of Asia Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 130. Rest of Asia Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 131. Rest of World Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 132. Rest of World Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 133. Rest of World Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 134. Rest of World Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 135. Rest of World Stomach Cancer Treatment Market Value, By Country, 2022-2031, Million USD
TABLE 136. Brazil Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 137. Brazil Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 138. Brazil Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 139. Brazil Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 140. Mexico Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 141. Mexico Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 142. Mexico Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 143. Mexico Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 144. South Africa Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 145. South Africa Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 146. South Africa Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 147. South Africa Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 148. Australia Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 149. Australia Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 150. Australia Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 151. Australia Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
TABLE 152. ROW Countries Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
TABLE 153. ROW Countries Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
TABLE 154. ROW Countries Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 155. ROW Countries Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
ROW Countries Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD

$2,000
$3,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings